303 related articles for article (PubMed ID: 8178948)
21. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
23. Bioactive IL-18 expression is up-regulated in Crohn's disease.
Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation.
McLaughlan JM; Seth R; Vautier G; Robins RA; Scott BB; Hawkey CJ; Jenkins D
J Pathol; 1997 Jan; 181(1):87-92. PubMed ID: 9072008
[TBL] [Abstract][Full Text] [Related]
25. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
26. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease.
Furusu H; Murase K; Nishida Y; Isomoto H; Takeshima F; Mizuta Y; Hewlett BR; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):639-43. PubMed ID: 12063959
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
Danelius M; Ost A; Lapidus AB
Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
32. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
33. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
34. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
[TBL] [Abstract][Full Text] [Related]
35. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
36. [Anatomopathological criteria of progression in chronic idiopathic colitis].
Jouret A; Juret A; Gerard R; Haot J
Acta Chir Belg; 1989; 89(2):96-100. PubMed ID: 2756807
[TBL] [Abstract][Full Text] [Related]
37. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.
Spieker T; Herbst H
Am J Pathol; 2000 Jul; 157(1):51-7. PubMed ID: 10880375
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease.
Brost S; Koschny R; Sykora J; Stremmel W; Lasitschka F; Walczak H; Ganten TM
Pathol Res Pract; 2010 Jan; 206(1):43-50. PubMed ID: 19954896
[TBL] [Abstract][Full Text] [Related]
39. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
40. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.
Playford RJ; Hanby AM; Patel K; Calam J
Am J Pathol; 1995 Feb; 146(2):310-6. PubMed ID: 7856742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
